Affimed N.V. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

View All

Latest Posts

About This Stock More About This Stock
Stocks Mixed At Midday, Still On Track For Solid Weekly Gains
Article By: Schaeffers Research
Friday, April 9, 2021 12:35 PM EDT
The Dow is up roughly 75 points this afternoon.
In this article: NDX, SPX, VIX, DJI, AFMD, ALEC, FUBO
Read
Morning Call For Wednesday, August 29
Article By: Jim Van Meerten
Wednesday, August 29, 2018 7:59 AM EDT
Sep E-mini S&Ps (ESU18 +0.04%) this morning are up +0.01% in quiet trade and rose on optimism that a U.S./Canada trade deal can be reached.
In this article: BOX, HRB, NCS, RCL, WTW, AVNW, PSEC, SCVL, AFMD, HPE, INST, TLRD, CDEV, ROKU, TLRY
Read
Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target
Article By: Scott Matusow
Monday, January 9, 2017 7:51 AM EDT
In the last part of our series on Calithera Biosciences we will be examining the company's second clinical asset and its acquisition chances sometime this year or early 2018.
In this article: CALA Also: GILD, BMY, AMGN, FPRX, AFMD
Read
Calithera Pharma In Focus, Part 1 - Checkpoint Inhibition
Article By: Scott Matusow
Wednesday, November 16, 2016 7:21 AM EDT
Clinical stage company Calithera presents an early stage investment opportunity with the ability to enhance therapeutic value to the first wave of IO therapeutics checkpoint inhibitors from Merck's Keytruda and Bristol-Myers Squibb's Opdivo.
In this article: CALA Also: AFMD, BMY, FPRX, BLUE, KITE, AZN, MRK, PFE, ADAP
Read
All Posts

Latest Tweets for $AFMD

No tweets yet!

PARTNER HEADLINES